Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Expenses by nature (Schedule of Expenses by Nature) (Details)

v3.19.1
Expenses by nature (Schedule of Expenses by Nature) (Details) - CAD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Feb. 15, 2018
Jun. 21, 2017
Dec. 31, 2018
Dec. 31, 2017
Expenses        
Salaries, wages and benefits     $ 5,945 $ 4,025
Other research and development expenditures, including clinical costs     8,398 3,045
Professional and consulting fees $ 285 $ 391 1,987 1,231
Travel     550 225
Office, rent and telecommunications     586 414
Insurance     444 81
Marketing, communications and investor relations     1,370 1,154
Depreciation     325 140
Stock-based compensation     1,182 571
Deferred share unit compensation     508 1,147
Other     800 329
Accreted interest     1,385 966
Research and development tax credits     (1,027) (537)
Government assistance     (35) (542)
Total Expenses     $ 22,418 $ 12,249